Filing Details
- Accession Number:
- 0001493152-22-036596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-27 17:51:58
- Reporting Period:
- 2022-12-22
- Accepted Time:
- 2022-12-27 17:51:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1695357 | Provention Bio Inc. | PRVB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1728920 | Francisco Leon | C/O Provention Bio, Inc. 55 Broad Street, 2Nd Floor Red Bank NJ 07701 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-22 | 1,568 | $2.50 | 1,574,568 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-22 | 1,568 | $10.00 | 1,573,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-23 | 375 | $2.50 | 1,573,375 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-23 | 375 | $10.00 | 1,573,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-12-22 | 1,568 | $0.00 | 1,568 | $2.50 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-12-23 | 375 | $0.00 | 375 | $2.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 540,152 | 2027-04-25 | No | 4 | M | Direct | |
| 539,777 | 2027-04-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,000,000 | Indirect | By Trust |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.005 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- The option is fully vested.
Billionaire Hedge Funds
